Is D51 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of D51 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: D51 (€68) is trading below our estimate of fair value (€84.9)
Significantly Below Fair Value: D51 is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for D51?
Key metric: As D51 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for D51. This is calculated by dividing D51's market cap by their current
earnings.
What is D51's PE Ratio?
PE Ratio
42.2x
Earnings
US$220.90m
Market Cap
US$9.32b
D51 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: D51 is expensive based on its Price-To-Earnings Ratio (42.2x) compared to the European Personal Products industry average (21.8x).
Price to Earnings Ratio vs Fair Ratio
What is D51's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
D51 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
42.2x
Fair PE Ratio
24x
Price-To-Earnings vs Fair Ratio: D51 is expensive based on its Price-To-Earnings Ratio (42.2x) compared to the estimated Fair Price-To-Earnings Ratio (24x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst D51 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€68.00
€67.06
-1.4%
9.4%
€79.90
€54.22
n/a
14
Nov ’25
€61.50
€62.74
+2.0%
8.2%
€69.27
€52.65
n/a
14
Oct ’25
€54.00
€58.54
+8.4%
8.7%
€65.22
€45.30
n/a
13
Sep ’25
€49.20
€58.07
+18.0%
8.7%
€64.78
€44.99
n/a
13
Aug ’25
€46.80
€59.13
+26.3%
8.3%
€64.67
€46.20
n/a
15
Jul ’25
€52.50
€60.99
+16.2%
7.8%
€65.54
€46.82
n/a
14
Jun ’25
€52.00
€60.62
+16.6%
7.8%
€65.68
€46.25
n/a
15
May ’25
€51.50
€58.09
+12.8%
7.1%
€62.90
€46.94
n/a
16
Apr ’25
€55.00
€56.17
+2.1%
7.4%
€61.20
€45.67
n/a
14
Mar ’25
€53.00
€56.49
+6.6%
7.3%
€61.83
€46.14
n/a
14
Feb ’25
€50.50
€53.48
+5.9%
8.4%
€61.64
€46.00
n/a
15
Jan ’25
€49.60
€51.05
+2.9%
8.9%
€59.54
€42.14
n/a
15
Dec ’24
€48.00
€47.96
-0.09%
7.4%
€52.35
€39.50
n/a
14
Nov ’24
€40.60
€43.73
+7.7%
4.6%
€47.31
€40.69
€61.50
14
Oct ’24
€38.20
€42.11
+10.2%
4.3%
€46.36
€39.74
€54.00
14
Sep ’24
€37.60
€41.07
+9.2%
4.2%
€45.30
€38.82
€49.20
14
Aug ’24
€32.20
€38.52
+19.6%
5.4%
€42.25
€35.96
€46.80
14
Jul ’24
€33.00
€38.98
+18.1%
5.9%
€42.96
€35.65
€52.50
14
Jun ’24
€33.80
€38.80
+14.8%
5.7%
€42.80
€35.52
€52.00
15
May ’24
€32.40
€35.44
+9.4%
5.3%
€38.10
€31.75
€51.50
15
Apr ’24
€30.20
€33.39
+10.6%
9.1%
€38.74
€26.75
€55.00
15
Mar ’24
€28.60
€32.93
+15.1%
11.6%
€39.44
€23.48
€53.00
16
Feb ’24
€25.60
€29.50
+15.2%
12.1%
€36.88
€23.05
€50.50
16
Jan ’24
€24.00
€30.03
+25.1%
12.2%
€37.67
€23.55
€49.60
17
Dec ’23
€23.60
€30.33
+28.5%
14.1%
€38.39
€24.00
€48.00
15
Nov ’23
€24.00
€32.69
+36.2%
12.8%
€41.12
€26.73
€40.60
15
Analyst Forecast: Target price is lower than the current share price.